The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
/in Breast Cancer, Glioblastoma, International Publications, Malignant Melanoma, Newcastle Disease Virus, Pancreatic Cancer /von 2018-09-26 / Cancers (Basel) 2018 Sep;10(10)Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2
/in Breast Cancer, Checkpoint-Inhibitors, Hyperthermia, International Publications /von 2018-09-07 / Integr Cancer Ther 2018 12;17(4):1297-1303Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2018-06-19 / Clin. Cancer Res. 2018 Oct;24(19):4900-4912Non-Invasive Radiofrequency Field Treatment of 4T1 Breast Tumors Induces T-cell Dependent Inflammatory Response
/in Breast Cancer, Hyperthermia, International Publications /von 2018-02-22 / Sci Rep 2018 Feb;8(1):3474A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2018-01-10 / Oncotarget 2018 Feb;9(11):10110-10117Association of autologous AdHER2 dendritic cell vaccination with antitumor activity and number of circulating tumor cells.
/in Breast Cancer, Dendritic Cells, International Publications /von 2017-06-05 / J Clin Oncol 35, 2017 (suppl; abstr 3089)Reirradiation for locally recurrent breast cancer
/in Breast Cancer, Hyperthermia, International Publications /von 2017-04-07 / Breast 2017 Jun;33:159-165Optimizing non-invasive radiofrequency hyperthermia treatment for improving drug delivery in 4T1 mouse breast cancer model
/in Breast Cancer, Hyperthermia, International Publications /von 2017-03-13 / Sci Rep 2017 03;7:43961Progress in Vaccine Therapies for Breast Cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2017-01-01 / Adv Exp Med Biol 2017;1026:315-330IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de